{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "H. R. 3392"}, "official-title": {"#tail": "\n  ", "#text": "To amend title XVIII of the Social Security Act to provide for a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under part D of the Medicare program, and for other purposes."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20131030", "#text": "October 30, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HWM00", "#text": "Ways and Means"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Bilirakis", "@name-id": "B001257"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Ben Ray Luj\u00e1n of New Mexico", "@name-id": "L000570"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HAC0B7299DD2F467480E2F26E6965C82E", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title; table of contents"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": {"short-title": {"#tail": "\n          ", "#text": "Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013"}, "#tail": ".", "#text": "\n            "}, "#text": "This Act may be cited as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Short title"}, "#text": "\n        ", "@id": "H5485329A041C45808AFFD6FFBBDE20CC"}, {"#tail": "\n    ", "text": {"#tail": "\n        ", "#text": "The table of contents of this Act is as follows:"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Table of contents"}, "toc": {"@container-level": "legis-body-container", "#tail": "\n      ", "@lowest-level": "section", "@regeneration": "yes-regeneration", "toc-entry": [{"@idref": "H2F16AC99FD20447F9981DE342CF5A3D4", "#tail": "\n          ", "#text": "Sec.\u20021.\u2002Short title; table of contents.", "@level": "section"}, {"@idref": "HC6BC3D676A1A46F0BBAFC6D18EFF77D7", "#tail": "\n          ", "#text": "Sec.\u20022.\u2002Establishing PDP safety program to prevent fraud and abuse in Medicare prescription drug plans.", "@level": "section"}, {"@idref": "H1F6FE22FF3F142649500E5F76587464D", "#tail": "\n          ", "#text": "Sec.\u20023.\u2002Part D suspension of claims payment.", "@level": "section"}, {"@idref": "HB5D8B2729502477EA12FE86C39892B90", "#tail": "\n          ", "#text": "Sec.\u20024.\u2002Improving activities of Medicare Drug Integrity Contractors (MEDICs).", "@level": "section"}, {"@idref": "H76262ABCFAA84AA2BF32B3311D838DAC", "#tail": "\n        ", "#text": "Sec.\u20025.\u2002Requiring e-prescribing for coverage of covered part D controlled substances.", "@level": "section"}], "@quoted-block": "yes-quoted-block", "@lowest-bolded-level": "division-lowest-bolded", "#text": "\n          "}, "#text": "\n        ", "@id": "H1B3FDC7C8878463FBD26E8892CCEF79E"}], "#text": "\n      ", "@id": "H2F16AC99FD20447F9981DE342CF5A3D4"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Establishing PDP safety program to prevent fraud and abuse in Medicare prescription drug plans"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20134(c) of the Social Security Act", "@value": "Social Security Act/s:1860D\u20134/ss:c"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013104(c)", "@value": "usc/42/1395w\u2013104/c"}, "@parsable-cite": "usc/42/1395w-104", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "PDP safety program"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "paragraph (1)(D)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:1/sp:D"}, "#text": "in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "H4CC0B2225190400F9E3EF8D47F6067FE", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "quote": [{"short-title": {"#tail": "\n              ", "#text": ", designed to"}, "#tail": " after ", "#text": "\n                "}, {"#tail": "; and", "#text": "program"}], "#text": "by inserting "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "H0363854529FE40968F533A794661EC4C"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4"}, "#text": ", that includes the procedures described in "}, {"#tail": "; and", "#text": "waste"}], "#text": "by inserting "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H968658BAE16C49F0BA3AFE0EEFECE69F", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n          ", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n        ", "paragraph": {"#tail": "\n            ", "subparagraph": [{"#tail": "\n              ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and the sponsor (or MA organization), and to notify such individuals that they have been so identified;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to identify an individual who has obtained coverage for a covered part D drug that is a frequently abused schedule II, III, IV, or V controlled substance, as determined in accordance with utilization guidelines established by the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "HCFFB7978D1364DD090F3A5686BD2B420", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "subparagraph (C)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:C", "@proposed": "true"}, "#text": "to contract with pharmacies authorized to dispense such controlled substances to create a safe pharmacy network that meets the criteria specified in "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "HD385CD4B39BE46F5AF866F189E9D38AB", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (or under ", "@entity-type": "act", "#text": "clause (i)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:i", "@proposed": "true"}, {"#tail": ") to drugs dispensed by one or more pharmacies contracted with under ", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:B", "@proposed": "true"}, {"#tail": ";", "@entity-type": "act", "#text": "clause (ii)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:ii", "@proposed": "true"}], "#text": "taking into account the location of the individual\u2019s residence (or residences), work site, mobility, and other relevant factors, to limit coverage to schedule II, III, IV, or V controlled substances for some or all classes of covered part D drugs for an individual identified under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "HE4675BB709FD4D5D8752D7656D4476B3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " the name, and other information that the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may require, of individuals so identified and of the fact of such individual\u2019s disenrollment (if any) from the plan of the sponsor (or the MA\u2013PD plan offered by the MA organization);", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "to provide to the "}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "#text": "\n                  ", "@id": "H064A45DB8AE54130B5B7045C1C89F6D8", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "to provide for an appeals process whereby an individual so identified may appeal such identification on the basis that the identification was not appropriate;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(v)"}, "@id": "H78EF5D22A3DB4101908045511FC5406F", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "to provide for a process whereby an individual so identified may petition for the termination of such identification on the basis that the limitation on coverage is no longer necessary to prevent fraud and abuse by the individual; and"}, "enum": {"#tail": "\n                  ", "#text": "(vi)"}, "@id": "HA59CDAB869294311B7D6E3A1CB322C89", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", except in such exceptional circumstances as the ", "@entity-type": "act", "#text": "subsection (e)", "@value": "Social Security Act/s:1860D\u20134/ss:e"}, {"#tail": " may permit.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "to provide that coverage shall be provided for a schedule II, III, IV, or V controlled substance only if it prescribed in accordance with an electronic prescribing program under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(vii)"}, "@id": "HD9FC81E785BC4FC6BC8FD920EFF3F561", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(A)"}, "header": {"#tail": "\n                ", "#text": "PDP sponsor procedures"}, "text": {"#tail": "\n                ", "#text": "A PDP sponsor (or an MA organization offering an MA\u2013PD plan) shall have in place procedures designed\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n                ", "@id": "HCB5A9E6131BE4DB5A3F11D8EFBAD931D"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall share information, with respect to the identity of an individual identified under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " who disenrolls from a plan under ", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:i", "@proposed": "true"}, {"#tail": ", with a PDP sponsor (or MA organization) that subsequently enrolls such individual under another plan in order that the provisions of ", "@entity-type": "act", "#text": "subparagraph (A)(iv)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:iv", "@proposed": "true"}, {"#tail": " would apply under such subsequent enrollment.", "@entity-type": "act", "#text": "subparagraph (A)(iii)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:iii", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "header": {"#tail": "\n                ", "#text": "Sharing information for subsequent plan enrollments"}, "#text": "\n                ", "@id": "HE17C79EAE13F4B609443B5514CB32441", "@commented": "no"}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "The pharmacies in the network are able to properly monitor the usage of schedule II, III, IV, and V controlled substances.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H9AA7817E92214EF49E86A71EB08EE65D", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " or the PDP sponsor (or MA organization) determines to be appropriate, such as use of a State prescription drug monitoring program, if such a program is available in the State.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Such pharmacies and network meet such other drug safety criteria as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H7B53E3FD255945D88070AD4B79800B04", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(C)"}, "header": {"#tail": "\n                ", "#text": "Safe pharmacy network criteria"}, "text": {"#tail": "\n                ", "#text": "The criteria specified in this subparagraph for a safe pharmacy network are the following:"}, "#text": "\n                ", "@id": "H07E0FC7BD6324499883B7C6C5BF92E3E"}], "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Safe pharmacy access program"}, "#text": "\n              ", "@id": "H5557337CD8E844FAA768C0E663221030"}, "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "H30EF1A0CB5F24A81B7974A5A145837E4"}, "#text": "\n          ", "@id": "HB66799C5D740451AB3FD3DAC29E2772A"}], "#text": "\n        ", "@id": "H94EECC5BBAD948C39E681617D4A86017"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": [{"#tail": " after ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may establish for individuals identified pursuant to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "\n          ", "@entity-type": "act", "#text": "section 1860D\u20134(c)(4)(A)(i)", "@value": "Social Security Act/s:1860D\u20134/ss:c/p:4/sp:A/cl:i", "@proposed": "true"}], "#text": ", subject to such limits as the "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "the "}], "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20131(b)(3)(D) of the Social Security Act", "@value": "Social Security Act/s:1860D\u20131/ss:b/p:3/sp:D"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013101(b)(3)(D)", "@value": "usc/42/1395w\u2013101/b/3/D"}, "@parsable-cite": "usc/42/1395w-101", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Dual eligibles"}, "#text": "\n        ", "@id": "H9A7E07ED2AB046D1A48A6ECCC81D3576", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "The amendments made by this section shall apply with respect to plan years beginning after the date that is 8 months after the date of the enactment of this Act.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "HE2F78E5B943A4B64AC60C1D643C2919B", "@commented": "no"}], "#text": "\n      ", "@id": "HC6BC3D676A1A46F0BBAFC6D18EFF77D7"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "Amend ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new subparagraph:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "1860D\u201312(b)(4) of the Social Security Act", "@value": "Social Security Act/s:1860D\u201312/ss:c/p:4"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013112(b)(4)", "@value": "usc/42/1395w\u2013112/b/4"}, "@parsable-cite": "usc/42/1395w-112", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Part D suspension of claims payment"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "@id": "H78FAADB6E5514DAAA262AD02E5F00E2D", "@display-inline": "no-display-inline", "#text": "\n        ", "subparagraph": {"#tail": "\n        ", "clause": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ") against the pharmacy, unless the ", "@entity-type": "act", "#text": "clause (ii)", "@value": "Social Security Act/s:1860D\u201312/ss:c/p:4/sp:H/cl:ii", "@proposed": "true"}, {"#tail": " determines there is a good cause not to suspend payments.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "A PDP sponsor may suspend payments and clean claim notifications to a pharmacy pending an investigation of a credible allegation of fraud (as defined in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "HF63EF7BA02C94BEAB27F8C0718A6BFA4"}, {"#tail": "\n          ", "subclause": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "a complaint made on the Medicare fraud hotline;"}, "enum": {"#tail": "\n              ", "#text": "(I)"}, "@id": "H6D3995EA09A0457C9E7317AE2998BDCF", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "detection of potential fraud through the analysis of claims data;"}, "enum": {"#tail": "\n              ", "#text": "(II)"}, "@id": "H97081000322B472E81259C8214660B22", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "detection of potential fraud through identification of inappropriate dispensing through audits, civil false claims cases, and law enforcement investigations; and"}, "enum": {"#tail": "\n              ", "#text": "(III)"}, "@id": "HE847B8E2222149FEA1513B5D55FFF4C1", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "claims referred to Medicare drug integrity contractors (MEDICs)."}, "enum": {"#tail": "\n              ", "#text": "(IV)"}, "@id": "H3796076918CD442AAD7F94EEB49E21DA", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(ii)"}, "header": {"#tail": "\n            ", "#text": "Credible allegation of fraud defined"}, "text": {"#tail": "\n            ", "term": {"#tail": " includes\u2014", "#text": "credible allegation of fraud"}, "#text": "In this subparagraph, the term ", "@display-inline": "yes-display-inline"}, "#text": "\n            ", "@id": "HC6915FB836F548FC9AE6288A944D5144"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "#text": "Nothing in this subparagraph shall be construed as limited the authority of a PDP sponsor to conduct post-claim payment review."}, "enum": {"#tail": "\n            ", "#text": "(iii)"}, "header": {"#tail": "\n            ", "#text": "Rule of construction"}, "#text": "\n            ", "@id": "H5F562EB3FAEB4E84844286BBE305AEB7"}], "enum": {"#tail": "\n          ", "#text": "(H)"}, "header": {"#tail": "\n          ", "#text": "Suspension of payments pending investigation of credible allegations of fraud by pharmacies"}, "#text": "\n          ", "@id": "H8FEEFD368D5B43AFB5309B2436CD1A93"}}, "#text": "\n      ", "@id": "H1F6FE22FF3F142649500E5F76587464D"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Improving activities of Medicare Drug Integrity Contractors (MEDICs)"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following new subsection:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1893 of the Social Security Act", "@value": "Social Security Act/s:1893"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395ddd", "@value": "usc/42/1395ddd"}, "@parsable-cite": "usc/42/1395ddd", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n      ", "subsection": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(j)"}, "header": {"#tail": "\n            ", "#text": "Improving activities of Medicare Drug Integrity Contractors (MEDICs)"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall authorize MEDICs to directly obtain prescription and medical records from entities such as pharmacies, PDP and physicians.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "term": [{"#tail": ") with Medicare drug integrity contractors (each in this subsection referred to as a ", "#text": "MEDIC contract"}, {"#tail": "), the ", "#text": "MEDIC"}], "#text": "Under contracts entered into under this section (each in this subsection referred to as a ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Access to In general"}, "#text": "\n              ", "@id": "H9E5BCDD9EF084810B6E375F866F19773"}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "#text": "If a PDP sponsor refers information to a MEDIC for investigation, under the MEDIC contract the MEDIC must acknowledge receipt of the referral and must report back to the sponsor the result of the MEDIC\u2019s investigation within 45 days of the date of the referral and share such results with appropriate agencies, such as law enforcement officials and State licensing authority."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Requirement for acknowledgment of referrals"}, "#text": "\n              ", "@id": "H505F2E5A47F2446292F345661ADAEEF2"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall develop a uniform reporting criteria for the annual reporting of the results of investigations by MEDICs to the Secretary and to ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ". Each such annual report shall include information on the number of referrals for investigation made to a MEDIC, the average time required for investigation, the results of the investigation, and the number of results that were referred to the ", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": " and to State licensing officials for further investigations.", "@entity-type": "federal-body", "#text": "Inspector General of the Department of Health and Human Services", "@entity-id": "7504"}], "#text": "In order to assess the performance of MEDICs, the "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Uniform annual report criteria"}, "#text": "\n              ", "@id": "H29E2E77C4AA6406A87C32782384EB611"}], "#text": "\n            ", "@id": "HB0BD59B9B8E44A7980B3E65FD70B5F2B"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "HB6C3C98A5DA246679059AB01A2FCE057"}, "#text": "\n        ", "@id": "H5A091C951F3748B4BE1C87CCF02A0578"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall take effect on the date of the enactment of this Act and shall apply as quickly as possible to MEDIC contracts, including MEDIC contracts entered into before such date of enactment.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013/s:4/ss:a", "@proposed": "true"}, "#text": "The amendment made by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "HBA24B2FC718340E39FE797B4663CCD8F"}], "#text": "\n      ", "@id": "HB5D8B2729502477EA12FE86C39892B90"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Requiring e-prescribing for coverage of covered part D controlled substances"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u20134(e) of the Social Security Act", "@value": "Social Security Act/s:1860D\u20134/ss:e"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013104(e)", "@value": "usc/42/1395w\u2013104/e"}, "@parsable-cite": "usc/42/1395w-104", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": ". "}, "#tail": "\n      ", "paragraph": {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may specify, coverage shall not be provided for a covered part D drug under a prescription drug plan (or under an MA\u2013PD plan) for a schedule II, III, IV, or V controlled substance unless the prescription for the drug has been transmitted electronically in accordance with an electronic prescription drug program that meets the requirements of ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Social Security Act/s:1860D\u20134/ss:e/p:2"}], "#text": "Except in such emergent circumstances as the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(7)"}, "header": {"#tail": "\n            ", "#text": "Requirement of e-prescribing for controlled substances"}, "#text": "\n            ", "@id": "HC41F4E13C6154AE78EE6D2FEC9B93D16"}, "@display-inline": "no-display-inline", "#text": "\n          ", "@id": "HCDC4EEAF371C4079B013A1AEF792E40D"}, "#text": "\n        ", "@id": "H8009A39A21794B7E93B12F5236252194"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply to coverage of drugs prescribed on or after January 1, 2015.", "@entity-type": "act", "#text": "subsection (a)", "@value": "Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013/s:5/ss:a", "@proposed": "true"}, "#text": "The amendment made by "}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "HF12D0503A63742DE8B74378B3CA3E343"}], "#text": "\n      ", "@id": "H76262ABCFAA84AA2BF32B3311D838DAC"}], "#text": "\n    ", "@id": "HA0E236D12B9E4C8C9B6BDBAA6D141CD7"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-10-30"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 3392 IH: Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}